Insider Buying: Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Insider Acquires 47,600 Shares of Stock

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAGet Rating) insider Jeffrey S. Hackman purchased 47,600 shares of Comera Life Sciences stock in a transaction dated Friday, September 9th. The stock was bought at an average price of $2.06 per share, for a total transaction of $98,056.00. Following the completion of the purchase, the insider now owns 47,600 shares in the company, valued at approximately $98,056. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Comera Life Sciences Stock Performance

CMRA opened at $1.93 on Tuesday. The firm has a 50 day moving average of $2.46. Comera Life Sciences Holdings, Inc. has a 1-year low of $1.11 and a 1-year high of $11.44.

Institutional Investors Weigh In On Comera Life Sciences

A hedge fund recently bought a new stake in Comera Life Sciences stock. Bluefin Capital Management LLC purchased a new stake in Comera Life Sciences Holdings, Inc. (NASDAQ:CMRAGet Rating) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 27,511 shares of the company’s stock, valued at approximately $73,000. Bluefin Capital Management LLC owned approximately 0.21% of Comera Life Sciences at the end of the most recent quarter. 32.96% of the stock is currently owned by institutional investors.

About Comera Life Sciences

(Get Rating)

Comera Life Sciences Holdings, Inc, a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions.

Featured Articles

Receive News & Ratings for Comera Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comera Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.